GE Healthcare played to high-field enthusiasts visiting the RSNA exhibit floor Sunday, unveiling three MR scanners – one at 3T and two at 1.5T.
GE Healthcare played to high-field enthusiasts visiting the RSNA exhibit floor Sunday, unveiling three MR scanners - one at 3T and two at 1.5T.
The Signa HDx 3T and Signa HDx 1.5T are built on a 32-channel architecture and support advanced clinical applications, including PROPELLER for motion-resistant brain imaging, VIBRANT-XV breast scanning, LAVA-XV body imaging, and TRICKS-XV time-resolved angiography. The Signa HDe, a value-driven 1.5T scanner, comes in four- and eight-channel configurations, and sports a small footprint for easy installation.
The 3T and premium 1.5T systems feature a new XVRE reconstruction engine; advanced parallel imaging algorithms; new acquisition strategies; and an interlocking, high-density head, neck, and spine coil system.
Signa HDx 3T utilizes high-density coils developed for the company's previously launched HD 3T system, which will remain in the GE line-up. New this year is the Signa HD breast coil, which supports multi-dimensional parallel imaging and biopsy capability, and a high-density hybrid extremity coil.
Signa HDx takes the flagship position in GE's 1.5T portfolio. It utilizes a Signa HD peripheral vascular lower leg array, which provides images of the lower leg and foot vessels.
The value-oriented Signa HDe 1.5T builds on the high definition platform, but offers lower operating costs and requires less overall siting space. With a 30% smaller footprint than a typical 1.5T system, the scanner can be sited where most 1.5T MR systems cannot, according to the company. Installation can be performed in about one week.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
New Survey Explores Radiologist and Neurologist Comfort Level with AI Triage for Brain MRI
January 7th 2025Survey results revealed that 71 percent of clinicians preferred adjunctive AI in facilitating triage of brain MRI scans and 58 percent were comfortable utilizing AI triage without input from radiologists.